2026-09-21T09:49:09Z https://meral.edu.mm/oai

oai:meral.edu.mm:recid/5758 2021-12-13T04:09:04Z 1582963366982:1597649727009 user-um1

Plasma Microrna-21 Expression in Patients with Non-small Cell Lung Cancer Yin Mon Thant Win Naing Toe Sandar Lung cancer is one of the most common malignancies and is also the leading cancer-related death worldwide. Majority of which are non-small cell lung cancers. Five year survival rate of stage IV non-small cell lung cancer is approximately only 10% whereas for stage I disease, it can be as high as 80%. These data provide the rationale to improve the diagnosis of non-small cell lung cancer and to detect the disease at an earlier stage where the cure of the disease can be expected. 2020-02-15 http://hdl.handle.net/20.500.12678/0000005758 https://meral.edu.mm/records/5758